G24
Conditions
Interventions
Group 1: The study is divided in two phases, each with three months' duration. Within the first phase the usual BTX application will be performed. Furthermore the baseline values are collected and the
Sponsors
Universitätsklinikum Jena, Institut f. Physiotherapie
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Cervical dystonia diagnosed - Continuous treatment with botulinumtoxin in an three months interval - At least one year treatment with botulinumtoxin
Exclusion criteria
Exclusion criteria: - Contraindications for the physiotherapy treatment - Contraindications for the botulinumtoxin treatment - Refusal of the study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main object of this study is to validate the effectiveness of a multimodal PT program as an additional therapy to BTX injection versus BTX application alone. Primary objectives are the quality of life determined by the SF-36 score and the mobility of the cervical spine which will be detected by the measuring system ZEBRIS. These assessments will be collected at the beginning and repeated at an interval of six weeks until the end of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary object is the Toronto Western Spasmodic Rating Scale (TWSTRS) which includes severity, disability and pain of the cervical dystonia. Another secondary variable is the electrical activity from the concerned muscles measured by an surface electromyography. These assessments will be collected at the beginning and repeated at an interval of six weeks until the end of the study. | — |
Countries
Germany
Contacts
Public ContactA. Günther
Uniklinikum Jena, Hans-Berger-Klinik für Neurologie
Outcome results
None listed